leisure time -WSS

leisure time

author：hotspot 2025-08-25 07:27:05 - browse：686

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

A California biotech developing a combination therapy with the obesity drug Zepbound has raised a $170 million Series D round.

The company, BioAge, raised money from more than a dozen investors. Sofinnova Investments led the round, which also included Eli Lilly and Amgen’s venture arms and previous investor Andreessen Horowitz.

BioAge’s primary focus is in developing medications that boost a person’s healthspan, or the number of healthy years a person lives. The company has drugs in development for neuroinflammation and brain aging. But the majority of the Series D proceeds will be used to develop the company’s lead drug candidate azelaprag, which is being tested in combination with Zepbound. That drug program is what grabbed Sofinnova’s attention, according to managing partner Jim Healy, who recently became chairman of BioAge’s board.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Late stage cancers on the rise after pandemic delayed screenings

explore

WSS

The cancer stories no one wants to hear

Cybersecurity threat forces Lurie Children's to take systems offline

Heart disease in astronauts blamed on cosmic radiation

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Late stage cancers on the rise after pandemic delayed screenings

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

knowledge

leisure time

explore

At least 13 dead in Texas as scorching temps continue

What we need to know about Arena Bioworks

How to save PrEP access — and even expand it

Vertigo drug brings hope for rare neuron disorder, Niemann

Peter Hotez and the public health issue of online harassment

Congressmen charge Covid hearing ‘could have been an email’

Guidelines to prevent youth baseball injuries need more muscle

Group behind ProMed defends move to subscription

What does generative AI mean for health care? We asked experts

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

focus

'Null' research findings aren't empty of meaning. Let's publish them

Covid misinformation case heads to Supreme Court

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Even great ERs can’t make up for American health disparities

Late stage cancers on the rise after pandemic delayed screenings

2 officers injured in shooting in Orlando, police say

hotspot

focus

explore

entertainment